Biocon Limited (BOM:532523)
India · Delayed Price · Currency is INR 410.55
-7.90 (-1.89%)
At close: Jul 13, 2026
Biocon Market Cap
Biocon has a market cap or net worth of 665.07 billion as of July 13, 2026. Its market cap has increased by 41.85% in one year.
Market Cap
665.07B
Enterprise Value
806.47B
Revenue
169.27B
Ranking
n/a
PE Ratio
172.48
Stock Price
410.55
Market Cap Chart
Since April 7, 2004, Biocon's market cap has increased from 45.41B to 665.07B, an increase of 1,364.49%. That is a compound annual growth rate of 12.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 665.07B | 26.52% |
| Dec 31, 2025 | 525.64B | 20.22% |
| Dec 31, 2024 | 437.25B | 46.69% |
| Dec 29, 2023 | 298.08B | -4.59% |
| Dec 30, 2022 | 312.41B | -27.97% |
| Dec 31, 2021 | 433.73B | -21.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aarti Drugs | 36.18B |
| Hester Biosciences | 17.94B |
| Titan Biotech | 16.57B |
| CCME Global | 5.20B |
| Zenotech Laboratories | 2.72B |
| Bharat Immunologicals & Biologicals Corporation | 734.92M |
| Transgene Biotek | 233.37M |
| Hindustan Bio Sciences | 73.81M |